Seer to Report First Quarter 2026 Financial Results on May 13, 2026
Seer (Nasdaq: SEER) will report first-quarter 2026 financial results on May 13, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Seer (Nasdaq: SEER) will report first-quarter 2026 financial results on May 13, 2026. Management will host a live webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET. Live audio will be on the Investor section of Seer's website and an archived replay will follow.
Details
News Market Reaction – SEER
On Apr 30, the first trading day after this news, SEER closed 3.72% above the previous close.
Data tracked by StockTitan Argus for the Apr 30 session.
Key Figures
- Earnings date
- May 13, 2026
- Scheduled first quarter 2026 financial results release
- Webcast time PT
- 1:30 p.m. PT
- Start time for earnings conference call
- Webcast time ET
- 4:30 p.m. ET
- Start time for earnings conference call
Previous Earnings date Reports
-
Announced date and webcast details for Q4 and full-year 2025 results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the first quarter 2026 on Wednesday, May 13, 2026. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.
About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer's Proteograph Product Suite integrates proprietary engineered nanoparticles, automation instrumentation, optimized consumables, and advanced analytical software. Seer's products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.
Media Contact:
Patrick Schmidt
pr@seer.bio
Investor Contact:
Marissa Bych
investor@seer.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.